FolioLanternBeta
WGSGeneDx Holdings Corp.

Kevin Feeley

Chief Financial Officer at GeneDx Holdings Corp., as of Sep 18, 2026Sold $3.4M of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
45K
shares held after the latest filing, GeneDx Holdings Corp.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
40K
shares sold, past 12 months
17
days with sales
$557K
largest single day, Mar 26, 2026
1
company filed for

Share of stake sold at GeneDx Holdings Corp. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $53K to cover taxesOctNovDec 2025: $818K to cover taxesDecJan 2026: $30K to cover taxesJanFebMar 2026: $1.6M to cover taxes$1.6MMarApr 2026: $26K to cover taxesAprMayJun 2026: $314K to cover taxesJunJulAugSep 2026: $503K to cover taxesSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
GeneDx Holdings Corp. (WGS)Chief Financial OfficerSep 2, 2022Sep 18, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.